<DOC>
	<DOCNO>NCT02615145</DOCNO>
	<brief_summary>The interferon-free combination regimen Paritaprevir/r - Ombitasvir without Dasabuvir ( ABBVIE REGIMEN ) ± ribavirin ( RBV ) treatment chronic hepatitis C ( CHC ) show safe effective randomize control clinical trial strict inclusion exclusion criterion well control condition . This observational study first effectiveness research examine ABBVIE REGIMEN ± RBV , use accord local label , real world condition Germany clinical practice patient population .</brief_summary>
	<brief_title>Real World Evidence Effectiveness Paritaprevir/r - Ombitasvir , ± Dasabuvir , ± Ribavirin Patients With Chronic Hepatitis C - An Observational Study Germany ( LIFE-C )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>Treatmentnaïve experience patient confirm CHC , genotype 1 4 , receive combination therapy interferonfree ABBVIE REGIMEN ± RBV accord standard care line local label . If RBV coadministered ABBVIE REGIMEN , prescribe line current local label ( special attention contraception requirement contraindication pregnancy ) Patients must voluntarily sign date patient authorization use and/or disclose his/her pseudonymized health data prior inclusion study Patient must participate intend participate concurrent interventional therapeutic trial Adolescents ; people treat accord label</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Quality life</keyword>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>Dasabuvir</keyword>
	<keyword>Observational Study</keyword>
	<keyword>Work-ability</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>Ombitasvir+Paritaprevir+Ritonavir</keyword>
	<keyword>Fibrosis</keyword>
</DOC>